High risk and sensitive group:induction chemotherapy

2 trials

Sponsors

Beijing Tongren Hospital, Capital Medical University

Conditions

head and neck cancer

Early Phase 1

Research of Precision Diagnosis and Treatment Based on Multi-omics in Advanced Laryngeal and Pharyngeal Cancer

Active, not recruitingChiCTR2200059671

Beijing Tongren Hospital, Capital Medical Universityhead and neck cancer

Start: 2022-06-01Updated: 2024-03-25

The molecular characterization in laryngeal and hypopharyngeal cancer based on the multi-omics study

Active, not recruitingChiCTR2200061066

Beijing Tongren Hospital, Capital Medical Universityhead and neck cancer

Start: 2022-06-01Updated: 2023-03-26